Effects of periconceptional folate on cognition in children of women with epilepsy: NEAD study
- PMID: 31871217
- PMCID: PMC7176294
- DOI: 10.1212/WNL.0000000000008757
Effects of periconceptional folate on cognition in children of women with epilepsy: NEAD study
Abstract
Objective: Emerging evidence suggests potential positive neuropsychological effects of periconceptional folate in both healthy children and children exposed in utero to antiseizure medications (ASMs). In this report, we test the hypothesis that periconceptional folate improves neurodevelopment in children of women with epilepsy by re-examining data from the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study.
Methods: The NEAD study was an NIH-funded, prospective, observational, multicenter investigation of pregnancy outcomes in 311 children of 305 women with epilepsy treated with ASM monotherapy. Missing data points were imputed with Markov chain Monte Carlo methods. Multivariate analyses adjusted for multiple factors (e.g., maternal IQ, ASM type, standardized ASM dose, and gestational birth age) were performed to assess the effects of periconceptional folate on cognitive outcomes (i.e., Full Scale Intelligence Quotient [FSIQ], Verbal and Nonverbal indexes, and Expressive and Receptive Language indexes at 3 and 6 years of age, and executive function and memory function at 6 years of age).
Results: Periconceptional folate was associated with higher FSIQ at both 3 and 6 years of age. Significant effects for other measures included Nonverbal Index, Expressive Language Index, and Developmental Neuropsychological Assessment Executive Function at 6 years of age, and Verbal Index and Receptive Language Index at 3 years of age. Nonsignificant effects included Verbal Index, Receptive Index, Behavior Rating Inventory of Executive Function-Parent Questionnaire Executive Function, and General Memory Index at 6 years of age, and Nonverbal Index and Expressive Index at 3 years of age.
Conclusions: Use of periconceptional folate in pregnant women with epilepsy taking ASMs is associated with better cognitive development.
Clinicaltrialsgov identifier: NCT00021866.
© 2019 American Academy of Neurology.
Figures
Comment in
-
Think Beyond Malformations: The Case for Periconceptional Folate in Women With Epilepsy.Epilepsy Curr. 2020 Jun 17;20(4):202-204. doi: 10.1177/1535759720932153. eCollection 2020 Jul-Aug. Epilepsy Curr. 2020. PMID: 34025229 Free PMC article. No abstract available.
References
-
- Center for Disease Control and Prevention. Folic Acid: Recommendations. Available at: cdc.gov/ncbddd/folicacid/recommendations.html. Accessed December 27, 2018.
-
- Chatzi L, Papadopoulou E, Koutra K, et al. . Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort “Rhea” study in Crete, Greece. Public Health Nutr 2012;15:1728–1736. - PubMed
-
- Julvez J, Fortuny J, Mendez M, et al. . Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort. Paediatr Perinat Epidemiol 2009;23:199–206. - PubMed